$40.53
-0.84 (-2.03%)
Performance
1D
—
1W
—
1M
—
3M
-24.36%
6M
+43.72%
1Y
+50.39%
YTD
-16.64%
Open$40.95
Previous Close$41.37
Day High$42.21
Day Low$40.14
52W High$56.05
52W Low$18.53
Volume—
Avg Volume1.34M
Market Cap2.91B
P/E Ratio—
EPS$-4.66
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$46.91
Below
SMA 200
$30.68
Above
RSI (14)
41.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
20 analysts
Price Target
+133.4% upside
Current
$40.53
$40.53
Target
$94.61
$94.61
$72.50
$94.61 avg
$144.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 672.08M | 640.49M | 736.20M |
| Net Income | -5,512,106 | -4,610,660 | -5,991,019 |
| Profit Margin | -0.8% | -0.7% | -0.8% |
| EBITDA | -7,633,568 | -6,751,763 | -9,172,286 |
| Free Cash Flow | -4,482,853 | -2,925,974 | -4,789,156 |
| Rev Growth | +20.0% | +11.6% | +0.9% |
| Debt/Equity | 0.79 | 0.70 | 0.90 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |